Anjarium Biosciences AG is a startup based in Switzerland, most recent round Series A, 1 tracked investor.
Anjarium Biosciences AG is a startup founded in 2018 based in Switzerland. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Anjarium Biosciences is a genetic medicine company developing a new generation of therapies. They utilize a proprietary platform with novel DNA-based gene vectors and a targeted delivery system to advance gene therapy and gene editing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.